Literature DB >> 7814358

Therapeutic considerations in treating depression in the elderly.

D L Dunner1.   

Abstract

The elderly depressed patient has a clinical picture unlike that of the younger individual. The pharmacokinetic profile, for example, changes in the normal aging process, which must be considered in choosing the proper antidepressant--and dosage--for an older person. Depressive illnesses are described in this review, with the focus on symptoms, prevalence, diagnosis, and treatment modalities. Cited are results of studies comparing tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs). Equivalent efficacy of the two classes of drugs was not unexpected. The higher degree of tolerability with SSRIs, however, should be of special interest to the clinician treating the elderly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814358

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.

Authors:  Tiffany W Chow; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2002 Sep-Oct       Impact factor: 2.035

2.  The added costs of depression to medical care.

Authors:  K Franco; M Tamburino; N Campbell; J Zrull; C Evans; D Bronson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

Review 3.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

4.  Antidepressant drug choice for first users in two regions in The Netherlands.

Authors:  A C Egberts; M Veenstra; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-06

Review 5.  Paroxetine: a review.

Authors:  M Bourin; P Chue; Y Guillon
Journal:  CNS Drug Rev       Date:  2001

Review 6.  Paroxetine: an update of its use in psychiatric disorders in adults.

Authors:  Antona J Wagstaff; Susan M Cheer; Anna J Matheson; Douglas Ormrod; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Anxiety and Depression: Optimizing Treatments.

Authors:  James C. Ballenger
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

Review 8.  Recent advances in geriatric psychopharmacology.

Authors:  C A Naranjo; N Herrmann; N Mittmann; K E Bremner
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.